Extent of resection in diffuse low-grade gliomas and the role of tumor molecular signature-a systematic review of the literature
- PMID: 32770298
- DOI: 10.1007/s10143-020-01362-8
Extent of resection in diffuse low-grade gliomas and the role of tumor molecular signature-a systematic review of the literature
Abstract
There is a lack of class I evidence concerning the impact of surgery in the treatment of diffuse low-grade glioma; the early maximal resection with preservation of eloquent brain areas has been accepted as the first therapeutic option. We performed a systematic review of the literature using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and protocol. Inclusion criteria: only case series with at least 100 patients containing supratentorial hemispheric diffuse low-grade glioma (according to any of the WHO classification used in papers published between 2000 to 2019), with pre- and postoperative MRI study were included in the qualitative and quantitative analyses. The extent of resection should be defined based on MRI at least in two categories and correlated with patients' outcomes (with univariate or multivariate analyses) using overall survival (OS) or malignant progression-free survival (MPFS). A total of 18 series with 4386 patients, published in 20 papers, were included in this systematic review. All the series that evaluates the relation between the extent of resection (EOR) and OS showed a statistically significant improvement of OS at univariate and/or multivariate analyzes with a greater EOR. Six studies showed a statistically significant improvement of MPFS with a greater EOR. We demonstrate that when a more rigorous analysis of EOR is performed, a benefit of a more aggressive resection on OS and MPFS is observed. Our review about EOR in different molecular groups of DLGG also suggests a benefit of maximum safe resection for all different subtypes, even though "radical surgery" may be associated with better OS and MPFS in tumors with a more aggressive signature.
Keywords: Extent of resection; Low-grade glioma; Molecular signature; Overall survival; Systematic review.
Similar articles
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
-
Antioxidants for female subfertility.Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD007807. doi: 10.1002/14651858.CD007807.pub4. Cochrane Database Syst Rev. 2020. PMID: 32851663 Free PMC article.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Antioxidants for female subfertility.Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Aug 27;8:CD007807. doi: 10.1002/14651858.CD007807.pub4 PMID: 28752910 Free PMC article. Updated. Review.
-
Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean.Cochrane Database Syst Rev. 2013 Jul 30;2013(7):CD010041. doi: 10.1002/14651858.CD010041.pub2. Cochrane Database Syst Rev. 2013. PMID: 23897547 Free PMC article. Review.
Cited by
-
A Personalized Longitudinal Strategy in Low-Grade Glioma Patients: Predicting Oncological and Neural Interindividual Variability and Its Changes over Years to Think One Step Ahead.J Pers Med. 2022 Oct 1;12(10):1621. doi: 10.3390/jpm12101621. J Pers Med. 2022. PMID: 36294760 Free PMC article. Review.
-
A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes.Biomed Res Int. 2021 Jun 16;2021:6680066. doi: 10.1155/2021/6680066. eCollection 2021. Biomed Res Int. 2021. Retraction in: Biomed Res Int. 2024 Mar 20;2024:9854370. doi: 10.1155/2024/9854370 PMID: 34222480 Free PMC article. Retracted.
-
Confocal laser endomicroscopy in glial tumors-a histomorphological analysis.Neurosurg Rev. 2024 Jan 24;47(1):65. doi: 10.1007/s10143-024-02286-3. Neurosurg Rev. 2024. PMID: 38265724 Free PMC article.
-
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA.Cancer Biol Med. 2022 Nov 1;19(10):1460-76. doi: 10.20892/j.issn.2095-3941.2022.0469. Cancer Biol Med. 2022. PMID: 36350010 Free PMC article.
-
Fluorescence Lifetime Imaging and Spectroscopic Co-Validation for Protoporphyrin IX-Guided Tumor Visualization in Neurosurgery.Front Oncol. 2021 Sep 14;11:741303. doi: 10.3389/fonc.2021.741303. eCollection 2021. Front Oncol. 2021. PMID: 34595120 Free PMC article.
References
-
- Ahmadi R, Dictus C, Hartmann C, Zurn O, Edler L, Hartmann M et al (2009) Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Acta Neurochir 151(11):1359–1365 - PubMed
-
- Bady P, Kurscheid S, Delorenzi M, Gorlia T, van den Bent MJ, Hoang-Xuan K, Vauléon É, Gijtenbeek A, Enting R, Thiessen B, Chinot O, Dhermain F, Brandes AA, Reijneveld JC, Marosi C, Taphoorn MJB, Wick W, von Deimling A, French P, Stupp R, Baumert BG, Hegi ME (2018) The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033. Acta Neuropathol 135(4):601–615. https://doi.org/10.1007/s00401-018-1810-6 - DOI - PubMed - PMC
-
- Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ Jr (2016) Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. N Engl J Med 374(14):1344–1355. https://doi.org/10.1056/NEJMoa1500925 - DOI - PubMed - PMC
-
- Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372(26):2481–2498
-
- Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, Pallud J, Peruzzi P, Baron MH, Kujas M, Guyotat J, Guillevin R, Frenay M, Taillibert S, Colin P, Rigau V, Vandenbos F, Pinelli C, Duffau H, _ _ Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article. J Neurosurg 2013;118(6):1157-1168. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical